Medicare Chief: Engage With Us On Payment Experiment
This article was originally published in Scrip
Executive Summary
Centers for Medicare & Medicaid Services (CMS) acting administrator Andy Slavitt entered the lion's den on March 9 and faced about 300 hundred drug company executives and other health care stakeholders at a meeting in Washington the day after releasing a controversial proposal to overhaul the way the government pays for outpatient prescription medicines, which had some industry leaders up in arms before it was even officially revealed.